IP Library Assignment 016633/0914
Patent Assignment
Reel/Frame 016633/0914

Assignment of Assignor's Interest

Recorded: 2005-08-08 Pages: 3
Assignor
ALNYLAM EUROPE AG
Executed: 2005-07-26
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property (1)
Nuclease Resistant Double-Stranded Ribonucleic Acid
Patent: 7,928,217 →
Application: 11/139,089 →
Publication: US 2006/0094678
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 8, 2005
From: VORNLOCHER, HANS-PETER; ROEHL, INGO; HADWIGER, PHILIPP
To: ALNYLAM EUROPE AG
Reel/Frame 016617/0443 →
Assignment of Assignor's Interest Sep 13, 2005
From: ZIMMERMANN, TRACY STAGE; MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; AKINC, AKIN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 016786/0903 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →